Guru Ownership Trend
Guru Analysis for Nektar Therapeutics (NKTR)
Nektar Therapeutics (NKTR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.27 M.
Top institutional holders include Jefferies Group and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $807,826 net outflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Nektar Therapeutics (NKTR)
Major holders include Jefferies Group ($2.66 M), Cliff Asness ($1.57 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 60,707 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $807,826, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 3 fully exited NKTR. The total reported sell value was $5.05 M.
Yes, 2 managers opened new positions in NKTR, and 0 increased their existing holdings. The total reported buy value was $4.24 M.